1984-2004: two decades of major regulatory change in the EU
This article was originally published in Clinica
Twenty years ago this month, Clinica's longest-serving journalist, Amanda Maxwell, started work on her first story for what has become the world's leading medical devices and diagnostics industry news publication. Here, she reflects on the enormous regulatory changes in the EU over that time and how they have impacted every corner of the world, and looks forward to Clinica, now under new ownership, continuing to deliver news services that meet readers' demands in this new era of information
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.